BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Prognosis
7 results:

  • 1. Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple-Negative breast cancer.
    Cao Y; Ge X; Zhu X; Han Y; Wang P; Akakuru OU; Wu A; Li J
    Adv Sci (Weinh); 2023 Jul; 10(21):e2300545. PubMed ID: 37147783
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers.
    Li GS; Chen G; Liu J; Tang D; Zheng JH; Luo J; Jin MH; Lu HS; Bao CX; Tian J; Deng WS; Fu JW; Feng Y; Zeng NY; Zhou HF; Kong JL
    BMC Pulm Med; 2022 Jun; 22(1):246. PubMed ID: 35751045
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations.
    Conforti F; Pala L; Pagan E; Rocco EG; Bagnardi V; Montagna E; Peruzzotti G; De Pas T; Fumagalli C; Pileggi S; Pesenti C; Marchini S; Corso G; Marchio' C; Sapino A; Graffeo R; Collet L; Aftimos P; Sotiriou C; Piccart M; Gelber RD; Viale G; Colleoni M; Goldhirsch A
    Breast; 2021 Oct; 59():94-101. PubMed ID: 34217971
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells.
    Bostanabad SY; Noyan S; Dedeoglu BG; Gurdal H
    Sci Rep; 2021 Jan; 11(1):1539. PubMed ID: 33452359
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
    Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
    Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin.
    Tacke F; Galm O; Kanig N; Yagmur E; Brandt S; Lindquist JA; Eberhardt CS; Raffetseder U; Mertens PR
    BMC Cancer; 2014 Jan; 14():33. PubMed ID: 24443788
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.
    Azzato EM; Driver KE; Lesueur F; Shah M; Greenberg D; Easton DF; Teschendorff AE; Caldas C; Caporaso NE; Pharoah PD
    Breast Cancer Res; 2008; 10(3):R47. PubMed ID: 18507837
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.